 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: LEMTRADA (Campath, alemtuzumab) |
|
***************************************************** |
|
#Post#: 2822-------------------------------------------------- |
|
(Abst.) ANCA-associated life-threatening systemic vasculitis aft |
|
er alemtuzumab treatment for MS |
|
By: agate Date: February 23, 2020, 7:20 pm |
|
--------------------------------------------------------- |
|
From PubMed (February 23, 2020), "ANCA-associated |
|
life-threatening systemic vasculitis after alemtuzumab treatment |
|
for multiple sclerosis" |
|
https://www.ncbi.nlm.nih.gov/pubmed/32081100 |
|
ANCA vasculitis: |
|
[quote][font=Roboto]ANCA vasculitis is an autoimmune disease |
|
affecting small blood vessels in the body. It is caused by |
|
autoantibodies called ANCAs, or |
|
[/font][font=Roboto][/size]A[/font][font=Roboto][/size]nti-[/fon |
|
t][font=Roboto][/size]N[/font][font=Roboto][/size]eutrophilic |
|
[/font][font=Roboto][/size]C[/font][font=Roboto][/size]ytoplasmi |
|
c |
|
[/font][font=Roboto][/size]A[/font][font=Roboto][/size]utoantibo |
|
dies. |
|
ANCAs target and attack a certain kind of white blood cells |
|
called neutrophils. They target a part of neutrophils called the |
|
cytoplasm (the inside of the cell.)[/font][/quote] |
|
[from the UNC Kidney Center Website] |
|
***************************************************** |
